Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
Sebastien Lobet, PhD at Saint-Luc University Clinics Cliniques, Co-founder of Activlim-Hemo, shared on LinkedIn:
”I had the honor of being invited to the Nordic Baltic Haemophilia Nurse and Physiotherapy Meeting, held over the past two days in Oslo.
I presented the ACTIVLIM-Hemo scale, a tool to assess activity limitations in adults with haemophilia, developed using a robust Rasch-based methodology.
The scale is unidimensional, linear, and reproducible, providing a reliable measure of functional performance.
ACTIVLIM-Hemo has been translated into 11 languages, with 5 already available.
It is freely accessible to all clinicians wishing to evaluate their patients’ activity limitations.
Developed by Prof. Massimo Penta (Arsalis and UCLouvain) and the Haematology Department of the Saint-Luc University Clinics Cliniques.
References:
Lobet S et al., Haemophilia, 2024. DOI: 10.1111/hae.14954
Lobet S et al., Haemophilia, 2023. DOI: 10.1111/hae.14705”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN